BioMedical Center opened
BioMedical Center BMC
(2.11.2015) The new BioMedical Center BMC has added an ultra-modern biomedical research complex to the high-tech campus operated by the Ludwig Maximilians University (LMU). On the recommendation of the German Science Council, the federal and state governments contributed funds totaling nearly EUR 150 million to the new research facility right on the edge of Munich.
Leading research and tuition
In its capacity as a center for applied cell research, the BMC is excellently endowed and has all the high technology it needs to pursue modern basic research. Resident scientists conduct research into disciplines such as biochemistry, molecular biology, immunology and epigenetics. The 450 staff who work here include three winners of the Leibniz Research Prize and are split across around 60 research groups.
The BMC also gives the LMU's Faculty of Medicine a completely revamped teaching infrastructure. For the preclinical part of medical degree courses, students can now attend the university's biggest lecture theater, whose 950 seats make it even larger than the Audimax in the main building. Seminar rooms, laboratories and a medium-sized lecture theater are dimensioned to handle as many as 2,000 students.
Fields of therapeutic research
Cell research focuses on studying the programs and communication strategies of human cells affected by serious illnesses. The hope is that this research will discover new approaches to the treatment of cancer, neurodegenerative disorders, metabolic conditions, autoimmune diseases and allergies, for example.
Central hub for interdisciplinary research
On both the organizational and content levels, the BMC is intended to build a bridge between research and clinical practice. Grosshadern Hospital is right next-door, and the high-tech campus is also home to the Faculties of Chemistry and Pharmacy (including the Gene Center), alongside the Faculty of Biology and the Institute for Stroke and Dementia Research. There are also the two Max Planck Institutes for Biochemistry and Neurobiology. In 2016, work to optimize public transport connections between the high-tech campus and Munich city center is scheduled to begin as the U6 subway line to Grosshadern is extended to Martinsried.
Munich: strong on biotechnology/life sciences
In 2014, the City of Munich and the Chamber of Industry and Commerce for Munich and Upper Bavaria commissioned a study entitled "The biotechnology and pharmaceutical industries in the Munich Metropolitan Region (EMM)". The study underscores the importance of the EMM region to the life sciences sector, pointing out that the development of 30 percent of Germany's biotechnological actives is based here, as are 15 percent of the country's biotech firms.